We have included patients in a comprehensive population-based IBD cohort from a catchment population of 2.95 million, and a unique biobank with materials from newly diagnosed and treatment-naïve IBD patients and symptomatic non-IBD controls. We believe this cohort will add important knowledge about IBD in the years to come.
No takes yet. Share an insight, caveat, or question.
Kristensen et al. (2021) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: